Key facts
- This page summarizes Patrick Spine's Form 4 filing for ACCURAY INC (ARAY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Dec 2022, 15:35.
Patrick Spine - 30 Nov 2022 Form 4 Insider Report for ACCURAY INC (ARAY)
- Reporting relationship
- SVP, Chief Admin Officer
- Issuer ticker
- ARAY
- Reported as of
- 30 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Dec 2022, 15:35:16 UTC
- Prior SEC filing
- 02 Nov 2022
- Next SEC filing
- 02 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Franco Palomba, Power of Attorney for Patrick Spine
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick Spine filed Form 4 for ACCURAY INC (ARAY) on 07 Dec 2022.
Change
- Previous filing in this sequence was filed on 02 Nov 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARAY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +88,580
- Change %
- +42%
- Price
- $0.000000
- Shares after
- 297,141
- Date
- 30 Nov 2022
- Ownership
- Direct
- Footnotes
- F1
ARAY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +88,580
- Change %
- +30%
- Price
- $0.000000
- Shares after
- 385,721
- Date
- 30 Nov 2022
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This represents a Performance Stock Unit grant on 11/30/22 with a performance end-date of 06/30/2025. The maximum payout potential is 150% and subject to continuous employment. The metrics weighting consisting of 75% company revenue and 25% EBIDTA Margin.
Footnote F2
This represents a Restricted Stock Unit grant with a grant date of 11/30/2022 that vest annually over three years from grant date.